|
Welcome to the Physical Pharmacy & Biopharmaceutics Section |
 |
PPB Section Chair Welcome Letter
Welcome to the PPB Section web page.
As the 2008-2009 PPB Section Chair, I encourage all members of AAPS to use our Section
as a resource, and to consider joining the Section as a Member if your career interests
involve physical pharmacy, biopharmaceutics, and drug delivery. The AAPS PPB Section
is comprised of members from diverse backgrounds in industry, academia, and government
who share a common interest in the field of drug discovery, preformulation, oral
absorption, and drug delivery. The PPB section was formed from the recent AAPS PDD
and PT Section strategic visioning.
The AAPS PPB Section aspires to make AAPS the premier global organization for scientists
involved in physicochemical and biopharmaceutical characterization and delivery
of small molecules and biologics. We provide a dynamic international forum for the
open interchange, discussion and dissemination of emerging scientific developments,
technologies, and regulatory knowledge regarding the principles and practices of
physical pharmacy and biopharmaceutics. We promote the continued growth and development
of the sciences underpinning physicochemical and biopharmaceutic characterization
of small molecules and biologics, pharmaceutical excipients and adjuvants, drug
candidate selection, drug transport and absorption, preformulation, and biopharmaceutic
data guiding the formulation and drug delivery strategies. We foster pharmaceutical
education, career growth, and professional development of the section membership.
Finally, we actively collaborate with and supporting other AAPS sections, focus
groups, and international professional/scientific organizations.
This is your Section; Section leadership exists to coordinate resources so that
we can best meet your needs. The 2008/2009 PPB Section Executive Committee welcomes
your participation and input. Please consider the many ways you can influence our
efforts through active participation as a volunteer. If you would like to discuss
the Section or ways you would like to be involved, contact AAPS or a member of our
Section's executive committee (provided on this Website).
I have been honored to be the chair of this section. I will endeavor to do honor
to serve the PPB section with the finest traditions of the AAPS organization. I
look forward to working with each and every one of you in 2008/2009.
Thanks,
Lawrence X. Yu
2008/2009 PPB Section Chair
Physical Pharmacy and Biopharmaceutics
The Physical Pharmacy and Biopharmaceutics (PPB) Section is composed of AAPS members
whose scientific interests are in the physicochemical and biological factors that
impact the design and delivery of small molecules and biologics. PPB is a multidisciplinary
section that focuses on preformulation, biopharmaceutics, drug absorption, nanotechnology,
and drug delivery systems design and performance including targeted drug delivery.
PPB provides an interactive forum for the exchange of information pertaining to
the selection of developable drug candidates at the drug discovery-development interface,
characterization of drug substance and excipients, studies of relationships between
drugs' physicochemical and biopharmaceutical properties and physiological considerations
at the cellular, organ, and whole animal levels, and overcoming drug absorption
and delivery barriers via drug delivery technologies.
|
|
|
|
|
|
|
|
|
|
Please check back frequently for more information about the brand new PPB Section!
The archived websites for the Pharmaceutics
and Drug Delivery (PDD) Section and the
Pharmaceutical Technologies (PT) Section
are still available for access.
|
|
|
Chair
Lawrence X. Yu, Ph.D.
Food and Drug Administration
North Potomac, MD United States
| Chair-Elect
Michael J. Hageman, Ph.D.
Bristol-Myers Squibb
Princeton, NJ UNITED STATES
| Vice Chair
Duxin Sun, Ph.D.
University of Michigan
Ann Arbor, MI UNITED STATES
| Secretary/Treasurer
Tycho H. Heimbach, Ph.D.
Novartis Pharmaceuticals Corporation
East Hanover, NJ UNITED STATES
| Member at Large
David Y. Mitchell, Ph.D.
NA
Lafayette, CO United States
| National Biotechnology Conference Screeners Committee
Lori S. Burton, Ph.D
Bristol-Myers Squibb, Inc.
New Brunswick, NJ UNITED STATES
| Annual Meeting Screeners Committee
Nathalie Y. Toussaint, Ph.D.
Bristol-Myers Squibb
Princeton, NJ United States
| Annual Meeting Program Committee
Michael J. Hageman, Ph.D.
Bristol-Myers Squibb
Princeton, NJ UNITED STATES
| Awards Committee
Lillian Zhang, Ph.D
CDER, FDA
Silver Spring, MD United States
| Content Advisory Cmte
Naushad M. Khan Ghilzai, Ph.D.
LECOM School of Pharmacy
Erie, PA United States
| National Biotech Progrming Committee
Rahul Rajan
Amgen Inc
Thousand Oaks, CA UNITED STATES
| Student/Postdoc Committee
AYMAN FAWZI EL-KATTAN, Ph.D
Pfizer Inc.
Groton, CT
| Fellows Committee
Gregory E. Amidon, Ph.D.
University of Michigan
Ann Arbor, MI United States
| Nominations Committee
Lawrence X. Yu, Ph.D.
Food and Drug Administration
North Potomac, MD United States
| Program Coordination Committee
Michael J. Hageman, Ph.D.
Bristol-Myers Squibb
Princeton, NJ UNITED STATES
| Communications Committee
Balvinder S. Vig, Ph.D
Bristol Myers Squibb
New Brunswick, NJ UNITED STATES
| Webmasters Committee
Sherry M. Ku
Wyeth Research
Pearl River, NY
| Member Strategic Oversight Committee
Pei Fan Bai, Ph.D.
FDA
Silver Spring, MD
| Staff Liaison
Maria Nadeau
AAPS
Arlington, VA UNITED STATES
| Staff Liaison
Peter Inchauteguiz
AAPS
Arlington, VA UNITED STATES
| Dermatopharmaceutics Focus Group
Carryn H. Purdon
Altana Inc
Melville, NY UNITED STATES
| Excipients Focus Group
Otilia M. Koo
Bristol-Myers Squibb Company
New Brunswick, NJ UNITED STATES
| Computational Drug Design Focus Group
Prof. Chang-Guo Zhan
University of Kentucky
Lexington, KY UNITED STATES
| Inhalation & Nasal Technology Focus Group
Mr. Dennis K. O'Connor
Boehringer Ingelheim Pharmaceuticals, Inc.
Ridgefield, CT UNITED STATES
| Intellectual Property Focus Group
Eyal H. Barash, J.D.
SSCI Inc
West Lafayette, IN UNITED STATES
| Lipid-Based Drug Delivery Systems Focus Group
Paul M. Bummer, Ph.D.
University of Kentucky
Lexington, KY UNITED STATES
| Microdialysis Focus Group
Dr. Grazia Stagni
Long Island University
Brooklyn, NY UNITED STATES
| Modified Release Focus Group
Joseph P. Reo, Ph.D.
Schering-Plough Corporation
Lakeland, TN United States
| Nanotechnology Focus Group
Patrick J. Sinko, Ph.D.
Rutgers University College of Pharmacy
Piscataway, NJ UNITED STATES
| Oral Absorption Focus Group
Huading Zhang, Ph.D.
Cell Genesys, Inc.
Foster City, CA UNITED STATES
| Preformulation Focus Group
Tapan K. Das, Ph.D.
Pfizer, St. Louis
Chesterfield, MO United States
| Targeted Drug Delivery and Prodrug Focus Group
Pei Fan Bai, Ph.D.
FDA
Silver Spring, MD
|
|